Prevention of second primary tumors by an acyclic retinoid in patients with hepatocellular carcinoma.
Muto
Y
Y
Moriwaki
H
H
Saito
A
A
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy* / Q000401:mortality; D005500:Follow-Up Studies; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000401:mortality; D016609:Neoplasms, Second Primary / Q000517:prevention & control*; D016019:Survival Analysis; D014212:Tretinoin / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000970:Antineoplastic Agents; D014212:Tretinoin; C034534:3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid